Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 6 studies | 29% ± 11% | |
interneuron | 5 studies | 29% ± 10% | |
GABAergic neuron | 4 studies | 30% ± 8% | |
glutamatergic neuron | 3 studies | 28% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2453.83 | 245 / 245 | 100% | 41.19 | 502 / 502 |
ovary | 100% | 2580.40 | 180 / 180 | 100% | 48.30 | 428 / 430 |
esophagus | 100% | 2350.92 | 1444 / 1445 | 99% | 22.13 | 182 / 183 |
breast | 100% | 1353.02 | 459 / 459 | 99% | 39.70 | 1103 / 1118 |
thymus | 100% | 2067.87 | 653 / 653 | 98% | 34.41 | 595 / 605 |
stomach | 100% | 1638.14 | 359 / 359 | 98% | 21.18 | 280 / 286 |
brain | 99% | 1647.67 | 2616 / 2642 | 99% | 23.90 | 697 / 705 |
intestine | 100% | 2217.65 | 966 / 966 | 97% | 19.08 | 512 / 527 |
skin | 100% | 1311.28 | 1807 / 1809 | 97% | 26.18 | 458 / 472 |
lung | 99% | 1168.32 | 573 / 578 | 97% | 24.03 | 1124 / 1155 |
pancreas | 97% | 896.61 | 319 / 328 | 97% | 17.45 | 172 / 178 |
bladder | 100% | 2241.52 | 21 / 21 | 94% | 18.07 | 473 / 504 |
uterus | 100% | 4168.74 | 170 / 170 | 92% | 23.11 | 421 / 459 |
adrenal gland | 100% | 1944.90 | 257 / 258 | 88% | 13.49 | 203 / 230 |
kidney | 100% | 1939.33 | 89 / 89 | 81% | 10.46 | 729 / 901 |
liver | 93% | 588.78 | 211 / 226 | 62% | 10.10 | 250 / 406 |
blood vessel | 100% | 1965.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 939.06 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.54 | 1 / 1 |
adipose | 100% | 1205.20 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 855.02 | 784 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1151.41 | 838 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 14.18 | 39 / 45 |
eye | 0% | 0 | 0 / 0 | 83% | 8.76 | 66 / 80 |
peripheral blood | 61% | 576.67 | 570 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 4.93 | 16 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0017015 | Biological process | regulation of transforming growth factor beta receptor signaling pathway |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_0014908 | Biological process | myotube differentiation involved in skeletal muscle regeneration |
GO_0045445 | Biological process | myoblast differentiation |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035019 | Biological process | somatic stem cell population maintenance |
GO_0005801 | Cellular component | cis-Golgi network |
GO_1990907 | Cellular component | beta-catenin-TCF complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016528 | Cellular component | sarcoplasm |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0008013 | Molecular function | beta-catenin binding |
Gene name | BCL9 |
Protein name | BCL9 transcription coactivator B-cell CLL/lymphoma 9 B-cell CLL/lymphoma 9 protein (B-cell lymphoma 9 protein) (Bcl-9) (Protein legless homolog) |
Synonyms | |
Description | FUNCTION: Involved in signal transduction through the Wnt pathway. Promotes beta-catenin's transcriptional activity (By similarity). . |
Accessions | ENST00000234739.8 Q1JQ81 O00512 ENST00000683836.1 A0A804HIV1 A0A804HI55 ENST00000684121.1 |